why choose us

First received: October 31, 2023

Clinical Trial: A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients With Diabetic Macular Edema

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Diabetic Macular Edema (DME)

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-Masked, Parallel-Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Diabetic

Brief Summary: The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.

Read more